In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Alpelisib is a drug for the treatment of HR/HER2- breast cancer, especially for ···【more】
Release date:2024-08-22Recommended:332
Alpelisib for the treatment of PIK3CA-mutated HR/HER2- advanced breast cancer in···【more】
Release date:2024-08-22Recommended:327
Alpelisib, approved in combination with fulvestrant in 2019 for the treatment of···【more】
Release date:2024-08-22Recommended:352
Anamorelin is a ghrelin receptor agonist used to treat cancer cachexia and signi···【more】
Release date:2024-08-22Recommended:283
Anamorelin is currently the only effective therapeutic drug that promotes appeti···【more】
Release date:2024-08-22Recommended:281
Koselugois a precision small molecule MEK blocker engineered for specific tumors···【more】
Release date:2024-08-22Recommended:324
Anamorelin is a ghrelin receptor agonist launched in Japan that brings a new tre···【more】
Release date:2024-08-22Recommended:307
Koselugois a precision small molecule MEK inhibitor designed for specific tumor ···【more】
Release date:2024-08-22Recommended:379
Koselugo is a carefully developed small molecule MEK blocker (also known as a mi···【more】
Release date:2024-08-22Recommended:368
As the world's first drug specifically for the treatment of cachexia, Anamor···【more】
Release date:2024-08-22Recommended:301
Anamorelin is a drug that mimics the function of ghrelin in the human body, whic···【more】
Release date:2024-08-22Recommended:288
Koselugo is a carefully developed small molecule MEK inhibitor (also known as a ···【more】
Release date:2024-08-22Recommended:321